Regentis Biomaterials closed a series D investment round on Feb 5.
Spinal Tech
Smith & Nephew saw a large growth in short interest during the month of January, according to The Vista Voice.
A clinical trial showed Mesoblast, a global leader in cell-based medicines, and its proprietary mesenchymal precursor cell product candidate, MPC-300-IV was safe and results in early and sustained clinical responses for patients with biologic refractory rheumatoid arthritis.
Mequon, Wisc.-based Titan Spine saw a 51 percent increase in sales of its Endoskeleton interbody fusion devices in 2015.
K2M Group Holdings' stock increased 2.08 percent in shorted shares, according to FDA News Alert.
Advertisement
A U.S. Northwest health plan has now approved coverage and reimbursement for a ReWalk personal exoskeleton system, according to StreetInsider.com.
LDR stock saw a decrease of 4.46 percent in short interest, according to an FDA News Alert report.
Quantitative Systematic Strategies increased its stake in NuVasive shares by 148.9 percent during the fourth quarter, according to an InterCooler report.
Medtech has sold another ROSA robotic surgery system to a hospital in France.
Stryker signed a deal to acquire Physio-Control in an all-cash transaction.